Indaptus Therapeutics (INDP) Stock Highlights

1 | -3.85%

2024-11-23 06:44:50

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacterias natural ability to activate both innate and adaptive cellular immune pathways. The companys pre-clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkins lymphoma in standard pre-clinical models.

Statistics

Range Today

0.84 1.04

Volume Today 102.5K

Range 1 Year

1.02 3.1

Volume 1 Year 14.4M

Range 3 Year

1.02 7.1

Volume 3 Year 66.96M

Range 10 Year

1.02 784

Volume 10 Year 439.09M

Highlights

Market Capitalization 12.13M (micro)

Floating Shares 7.48M

Current Price 1

Price To Earnings -0.68

Price To Book 1.65

Earnings Per Share -1.86

Payout Ratio 0%

Performance

Latest -3.85%

1 Month -35.9%

3 Months -39.02%

6 Months -62.69%

1 Year -51.92%

3 Years -82.49%

5 Years -97.4%

10 Years -99.79%

Benchmarks

Market Capitalization

0 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

0 / 368

Free Cashflow

0 / 352

Performance 5 years

0 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.